Properties of SARS-CoV-2 Delta and Delta Plus variants and efficacy of protection by different vaccination strategies. (IMAGE)

Deutsches Primatenzentrum (DPZ)/German Primate Center

Properties of SARS-CoV-2 Delta and Delta Plus variants and efficacy of protection by different vaccination strategies.

Caption

A) Summary of special properties of SARS-CoV-2 Delta and Delta Plus variants compared to the virus circulating to the beginning of the pandemic (wildtype virus). B) Heterologous vaccination with Oxford-AstraZeneca's vector-based vaccine and BioNTech-Pfizer's mRNA-based vaccine Induces the production of more neutralizing antibodies against the Delta variant than homologous (two-shot) vaccination with Oxford-AstraZeneca.

Credit

Markus Hoffmann

Usage Restrictions

The image material may only be used for editorial purposes referring to the German Primate Center. To this purpose, publication is authorized free of charge provided that the source is indicated. Any use for promotional or political purposes requires the prior authorization.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.